Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Glioma × 1 year × Clear all

Status

Sponsor Class

Study Type

Interventional 293 Observational 57 Expanded_access 1

Sponsor

Cancer Type

Conditions

Neoplasms 12 Multiple Myeloma 9 Recurrence 8 Carcinoma, Non-Small-Cell Lung 8 Prostatic Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Pancreatic Neoplasms 6 Ovarian Neoplasms 5 Neuroblastoma 5 Melanoma 5 Leukemia, Myeloid, Acute 5 Lymphoma, Large B-Cell, Diffuse 4 Cholangiocarcinoma 4 Breast Neoplasms 4 Stomach Neoplasms 3 Sarcoma 3 Non-Muscle Invasive Bladder Neoplasms 3 Neuroectodermal Tumors, Primitive 3 Lung Neoplasms 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Uterine Neoplasms 2 Urinary Bladder Neoplasms 2 Sarcoma, Ewing 2 Primary Myelofibrosis 2 Polycythemia Vera 2 Osteosarcoma 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06743100 2025-04-02

18F-Floretyrosine Expanded Access Program

Telix Pharmaceuticals (Innovations) Pty Limited

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡